Immediate Impact
1 from Science/Nature 27 standout
Citing Papers
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
2024 Standout
Works of John J. Ko being referenced
Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
2021
Increasing Patient Involvement in Drug Development
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| John J. Ko | 122 | 61 | 98 | 98 | 23 | 414 | |
| Chao-Sung Chang | 103 | 44 | 29 | 25 | 28 | 481 | |
| Huah Shin Ng | 67 | 27 | 155 | 47 | 34 | 504 | |
| Mwangi J. Murage | 32 | 59 | 35 | 62 | 31 | 410 | |
| Ansgar Hebborn | 44 | 44 | 28 | 128 | 11 | 461 | |
| Christoph Ohlmeier | 25 | 16 | 34 | 51 | 29 | 386 | |
| Marie‐Blanche Valnet‐Rabier | 92 | 35 | 92 | 25 | 28 | 447 | |
| R. Babela | 72 | 40 | 21 | 71 | 22 | 415 | |
| Kirsten F. L. Douma | 40 | 76 | 91 | 43 | 17 | 422 | |
| Marie‐Pierre Desrosiers | 19 | 45 | 34 | 32 | 15 | 480 | |
| Gorana Capkun | 78 | 9 | 262 | 32 | 24 | 499 |
All Works
Login with ORCID to disown or claim papers
Loading papers...